Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This ...

The phase 3 COAST trial investigating 2 mg sozinibercept for the treatment of wet age-related macular degeneration in ...

Age-related macular (AMD) degeneration ... are due to wet AMD. Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient ...

Vision loss is a growing concern in India, especially macular degeneration - a common eye condition. Once known to be ...

Opthea Ltd. is considering its options after lead candidate sozinibercept (OPT-302) failed the phase III Coast trial in wet age-related macular degeneration (AMD). The global Coast phase III trial ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet ...

Biotechnology firm Opthea has warned investors its solvency is in question after the failure of a major clinical trial into ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

Without treatment ... can be treated with surgery, and wet AMD can be treated with medications and laser therapies. However, the most common form of macular degeneration, dry AMD, causes permanent ...

Incorporate omega-3s into your diet: Foods like fish have been shown to reduce the risk of macular degeneration. Don’t forget to add a handful of walnuts to your meals as they’re also packed with ...